Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$9.17 USD
-0.05 (-0.54%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $9.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | 0.03 |
Last EPS Surprise | 175.00% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.39 |
Next Year | 0.26 |
EPS (TTM) | -0.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.54M | 15.93M | 67.15M | 89.81M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 15.75M | 17.18M | 71.59M | 96.50M |
Low Estimate | 13.90M | 14.90M | 63.90M | 85.61M |
Year ago Sales | 10.42M | 13.75M | 57.42M | 67.15M |
Year over Year Growth Est. | 39.54% | 15.85% | 16.93% | 33.75% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.13 | -0.39 | 0.26 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.26 | -0.16 | -0.45 | 0.09 |
High Estimate | -0.08 | -0.09 | -0.23 | 0.77 |
Low Estimate | -0.26 | -0.16 | -0.48 | -0.08 |
Year ago EPS | -0.24 | -0.13 | -0.39 | -0.39 |
Year over Year Growth Est. | 20.83% | 0.00% | 0.00% | 165.81% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.13 | -0.39 | 0.26 |
7 Days Ago | -0.19 | -0.13 | -0.39 | 0.26 |
30 Days Ago | -0.19 | -0.13 | -0.38 | 0.29 |
60 Days Ago | -0.19 | -0.11 | -0.15 | 0.37 |
90 Days Ago | -0.19 | -0.11 | -0.16 | 0.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.13 | -0.45 | 0.09 |
Zacks Consensus Estimate | -0.19 | -0.13 | -0.39 | 0.26 |
Earnings ESP | 0.00% | 0.00% | -16.38% | -65.39% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.03 | -0.01 | -0.13 | -0.24 | NA |
Estimate | -0.04 | -0.10 | -0.16 | -0.27 | NA |
Difference | 0.07 | 0.09 | 0.03 | 0.03 | 0.06 |
Surprise | 175.00% | 90.00% | 18.75% | 11.11% | 73.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more